This kit is a real-time RT-PCR multiplexed test intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, Influenza A virus, Influenza B virus and Respiratory Syncytial virus (A/B strain) nucleic acids in nasal swab specimens collected from suspected cases of respiratory viral infection consistent with Coronavirus disease 2019 (COVID-19), suspected clusters of cases, or other individuals who need COVID-19, Influenza A, Influenza B or Respiratory Syncytial virus (A/B strain) infection diagnosis or differentiation diagnosis.
The detection results of this kit should be regarded as a reference for clinical practice, but not as the sole standard for clinical diagnosis. It is suggested to make a comprehensive analysis combined with clinical symptoms and other laboratory testing methods.
The laboratory personnel for testing with Trans SARS-CoV-2, Influenza A/B and Respiratory Syncytial virus Assay should be professionally trained with gene amplification or molecular biology detection and qualified for related experimental operations. Biosafety protective equipment and programs are required for the laboratories.
Instruments
Validated Instrument in-house: ABI 7500 and StepOne Plus Real-Time PCR instrument
Instruments used by customers with revised interpretation for test results : ABI QuantStudio 3, Bio-Rad CFX96.
Please contact our Technical Support team for other instruments.
Storage
Store the kit at -20±5℃ away from light for 12 months.
Shipping
Ship the kit at low temperature. Dry ice should be used for long-distance shipping. Avoid repeated freeze-thaw cycles (freeze-thaw cycles should be fewer than 10).